FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361228367> ?p ?o ?g. }

• W4361228367 abstract "Abstract Assisted reproductive technologies (ART) have significantly impacted fertility treatment worldwide through innovations such as in vitro fertilization (IVF) and in vitro maturation (IVM). IVM holds promise as a technology for fertility treatment in women who cannot or do not wish to undergo conventional controlled ovarian stimulation (COS). However, IVM has historically shown highly variable performance in maturing oocytes and generating oocytes with strong developmental capacity. Furthermore, recently reported novel IVM approaches are limited to use in cycles lacking human chorionic gonadotropin (hCG) triggers, which is not standard practice in fertility treatment. We recently reported the development of ovarian support cells (OSCs) generated from human induced pluripotent stem cells (hiPSCs) that recapitulate dynamic ovarian function in vitro . Here we investigate the potential of the se OSCs in an IVM co-culture system to improve the maturation of human cumulus-enclosed immature oocytes retrieved from abbreviated gonadotropin stimulated cycles. We reveal that OSC-IVM significantly improves maturation rates compared to existing IVM systems. Most importantly, we demonstrate that OSC-assisted IVM oocytes are capable of significantly improving euploid blastocyst formation and yielding blastocysts with normal global and germline differential methylation region methylation profiles, a key marker of their clinical utility. Together, these findings demonstrate a novel approach to IVM with broad applicability to modern ART practice. Structured Abstract Objective To determine if in vitro maturation (IVM) of human oocytes can be improved by co-culture with ovarian support cells (OSCs) derived from human induced pluripotent stem cells (hiPSCs). Design Three independent experiments were performed in which oocyte donors were recruited to undergo abbreviated gonadotropin stimulation and retrieved cumulus oocyte complexes (COCs) were randomly allocated between the OSC-IVM and control IVM conditions. Subjects Across the three experiments, a total of 67 oocyte donors aged 19 to 37 years were recruited for retrieval using informed consent. Anti-mullerian hormone (AMH) value, antral follicle count (AFC), age, BMI, and ovarian pathology were used for inclusion and exclusion criteria. Intervention and Control The OSC-IVM culture condition was composed of 100,000 OSCs in suspension culture supplemented with human chorionic gonadotropin (hCG), recombinant follicle stimulating hormone (rFSH), androstenedione and doxycycline. IVM controls comprised commercially-available IVM media without OSCs and contained either the same supplementation as above (media-matched control), or FSH and hCG only (IVM media control). In one experiment, an additional control using fetal ovarian somatic cells (FOSCs) was used with the same cell number and media conditions as in the OSC-IVM. Main Outcome Measures Primary endpoints consisted of metaphase II (MII) formation rate and oocyte morphological quality assessment. A limited cohort of oocytes were utilized for secondary endpoints, consisting of fertilization and blastocyst formation rates with preimplantation genetic testing for aneuploidy (PGT-A) and embryo epigenetic analysis. Results OSC-IVM resulted in a statistically significant improvement in MII formation rate compared to the media-matched control, a commercially available IVM media control, and the FOSC-IVM control. Oocyte morphological quality between OSC-IVM and controls did not significantly differ. OSC-IVM displayed a trend towards improved fertilization, cleavage, and blastocyst formation. OSC-IVM showed statistically significant improvement in euploid day 5 or 6 blastocyst formation compared to the commercially available IVM media control. OSC-IVM embryos displayed similar epigenetic global and germline loci profiles compared to conventional stimulation and IVM embryos. Conclusion The novel OSC-IVM platform is an effective tool for maturation of human oocytes obtained from abbreviated gonadotropin stimulation cycles, supporting/inducing robust euploid blastocyst formation. OSC-IVM shows broad utility with different stimulation regimens, including hCG triggered and untriggered oocyte retrieval cycles, making it a highly useful tool for modern fertility treatment." @default.
• W4361228367 created "2023-03-31" @default.
• W4361228367 creator A5000502253 @default.
• W4361228367 creator A5005976151 @default.
• W4361228367 creator A5006242506 @default.
• W4361228367 creator A5009606540 @default.
• W4361228367 creator A5016342562 @default.
• W4361228367 creator A5017309395 @default.
• W4361228367 creator A5018511765 @default.
• W4361228367 creator A5022027061 @default.
• W4361228367 creator A5023413356 @default.
• W4361228367 creator A5023987698 @default.
• W4361228367 creator A5026466504 @default.
• W4361228367 creator A5032655726 @default.
• W4361228367 creator A5038662277 @default.
• W4361228367 creator A5039212863 @default.
• W4361228367 creator A5048262085 @default.
• W4361228367 creator A5056389825 @default.
• W4361228367 creator A5063964172 @default.
• W4361228367 creator A5067762619 @default.
• W4361228367 creator A5073138487 @default.
• W4361228367 creator A5074303879 @default.
• W4361228367 creator A5075250336 @default.
• W4361228367 creator A5078168892 @default.
• W4361228367 creator A5090149132 @default.
• W4361228367 date "2023-03-29" @default.
• W4361228367 modified "2023-09-28" @default.
• W4361228367 title "Human induced pluripotent stem cell-derived ovarian support cell co-culture improves oocyte maturation<i>in vitro</i>after abbreviated gonadotropin stimulation" @default.
• W4361228367 cites W1965380539 @default.
• W4361228367 cites W1976127531 @default.
• W4361228367 cites W1981484279 @default.
• W4361228367 cites W1986140299 @default.
• W4361228367 cites W1987069605 @default.
• W4361228367 cites W1990195465 @default.
• W4361228367 cites W2007767716 @default.
• W4361228367 cites W2017424446 @default.
• W4361228367 cites W2030083301 @default.
• W4361228367 cites W2039578770 @default.
• W4361228367 cites W2054167608 @default.
• W4361228367 cites W2067455227 @default.
• W4361228367 cites W2073748870 @default.
• W4361228367 cites W2084172300 @default.
• W4361228367 cites W2088825618 @default.
• W4361228367 cites W2100743191 @default.
• W4361228367 cites W2101734981 @default.
• W4361228367 cites W2109334201 @default.
• W4361228367 cites W2129017508 @default.
• W4361228367 cites W2131117364 @default.
• W4361228367 cites W2151415981 @default.
• W4361228367 cites W2152740733 @default.
• W4361228367 cites W2158662747 @default.
• W4361228367 cites W2159053644 @default.
• W4361228367 cites W2201243297 @default.
• W4361228367 cites W2271623863 @default.
• W4361228367 cites W2522831826 @default.
• W4361228367 cites W2591754421 @default.
• W4361228367 cites W2751304555 @default.
• W4361228367 cites W2900726594 @default.
• W4361228367 cites W2967065071 @default.
• W4361228367 cites W2968944381 @default.
• W4361228367 cites W2998037677 @default.
• W4361228367 cites W3006653136 @default.
• W4361228367 cites W3008412948 @default.
• W4361228367 cites W3040238808 @default.
• W4361228367 cites W3088410042 @default.
• W4361228367 cites W3092705594 @default.
• W4361228367 cites W3169544586 @default.
• W4361228367 cites W3182380636 @default.
• W4361228367 cites W3210887341 @default.
• W4361228367 cites W4205755962 @default.
• W4361228367 cites W4213435613 @default.
• W4361228367 cites W4223506514 @default.
• W4361228367 cites W4281772101 @default.
• W4361228367 cites W4289745711 @default.
• W4361228367 cites W4317721425 @default.
• W4361228367 cites W4321366558 @default.
• W4361228367 doi "https://doi.org/10.1101/2023.03.27.534479" @default.
• W4361228367 hasPublicationYear "2023" @default.
• W4361228367 type Work @default.
• W4361228367 citedByCount "0" @default.
• W4361228367 crossrefType "posted-content" @default.
• W4361228367 hasAuthorship W4361228367A5000502253 @default.
• W4361228367 hasAuthorship W4361228367A5005976151 @default.
• W4361228367 hasAuthorship W4361228367A5006242506 @default.
• W4361228367 hasAuthorship W4361228367A5009606540 @default.
• W4361228367 hasAuthorship W4361228367A5016342562 @default.
• W4361228367 hasAuthorship W4361228367A5017309395 @default.
• W4361228367 hasAuthorship W4361228367A5018511765 @default.
• W4361228367 hasAuthorship W4361228367A5022027061 @default.
• W4361228367 hasAuthorship W4361228367A5023413356 @default.
• W4361228367 hasAuthorship W4361228367A5023987698 @default.
• W4361228367 hasAuthorship W4361228367A5026466504 @default.
• W4361228367 hasAuthorship W4361228367A5032655726 @default.
• W4361228367 hasAuthorship W4361228367A5038662277 @default.
• W4361228367 hasAuthorship W4361228367A5039212863 @default.
• W4361228367 hasAuthorship W4361228367A5048262085 @default.
• W4361228367 hasAuthorship W4361228367A5056389825 @default.
• W4361228367 hasAuthorship W4361228367A5063964172 @default.
• W4361228367 hasAuthorship W4361228367A5067762619 @default.
• W4361228367 hasAuthorship W4361228367A5073138487 @default.

• next